These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3792469)

  • 1. The role of the low-molecular weight (less than or equal to 15,000 daltons) apoproteins of pulmonary surfactant.
    Suzuki Y; Curstedt T; Grossmann G; Kobayashi T; Nilsson R; Nohara K; Robertson B
    Eur J Respir Dis; 1986 Nov; 69(5):336-45. PubMed ID: 3792469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between physical and physiological properties of various preparations of lung surfactant.
    Nohara K; Berggren P; Curstedt T; Grossmann G; Nilsson R; Robertson B
    Eur J Respir Dis; 1986 Nov; 69(5):321-35. PubMed ID: 3792468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration dependence of a poly-leucine surfactant protein C analogue on in vitro and in vivo surfactant activity.
    Almlén A; Stichtenoth G; Robertson B; Johansson J; Curstedt T
    Neonatology; 2007; 92(3):194-200. PubMed ID: 17476119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants.
    Revak SD; Merritt TA; Hallman M; Heldt G; La Polla RJ; Hoey K; Houghten RA; Cochrane CG
    Pediatr Res; 1991 May; 29(5):460-5. PubMed ID: 1896249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung surfactant dysfunction in tuberculosis: effect of mycobacterial tubercular lipids on dipalmitoylphosphatidylcholine surface activity.
    Chimote G; Banerjee R
    Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):215-23. PubMed ID: 16198543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of exogenous surfactant by pulmonary edema fluid.
    Kobayashi T; Nitta K; Ganzuka M; Inui S; Grossmann G; Robertson B
    Pediatr Res; 1991 Apr; 29(4 Pt 1):353-6. PubMed ID: 1852528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of surfactant activity using purified human apoprotein and phospholipids measured in vitro and in vivo.
    Revak SD; Merritt TA; Hallman M; Cochrane CG
    Am Rev Respir Dis; 1986 Dec; 134(6):1258-65. PubMed ID: 3789526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged ventilation of the premature newborn rabbit after treatment with natural or apoprotein-based artificial surfactant.
    Robertson B; Curstedt T; Grossmann G; Kobayashi T; Kokubo M; Suzuki Y
    Eur J Pediatr; 1988 Feb; 147(2):168-73. PubMed ID: 3366134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of pulmonary surfactant by silicone oil in vitro and in ventilated immature rabbits.
    Stichtenoth G; Linderholm B; Almlén A; Björkman MH; Byman I; Nordling K; Robertson B; Johansson J; Herting E; Curstedt T
    Crit Care Med; 2009 May; 37(5):1750-6. PubMed ID: 19325472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated image analysis of alveolar expansion patterns in immature newborn rabbits treated with natural or artificial surfactant.
    Halliday H; Robertson B; Nilsson R; Rigaut JP; Grossmann G
    Br J Exp Pathol; 1987 Oct; 68(5):727-32. PubMed ID: 3689674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in pulmonary surfactant research with special reference to surfactant apoproteins].
    Akino T; Kuroki Y
    Kokyu To Junkan; 1990 Aug; 38(8):722-35. PubMed ID: 2218080
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural and functional aspects of protein: phospholipid interactions in surfactant.
    Benson BJ; Hawgood S
    Eur J Respir Dis Suppl; 1985; 142():29-36. PubMed ID: 3860394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo.
    Yukitake K; Brown CL; Schlueter MA; Clements JA; Hawgood S
    Pediatr Res; 1995 Jan; 37(1):21-5. PubMed ID: 7700729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in molecular biology with respect to pulmonary surfactant apoproteins].
    Kuroki Y; Ogasawara Y
    Nihon Rinsho; 1996 Feb; 54(2):334-40. PubMed ID: 8838078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological activity of pulmonary surfactant with low protein content: effect of enrichment with synthetic phospholipids.
    Berggren P; Curstedt T; Grossman G; Nilsson R; Robertson B
    Exp Lung Res; 1985; 8(1):29-51. PubMed ID: 3846531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity.
    Curstedt T; Jörnvall H; Robertson B; Bergman T; Berggren P
    Eur J Biochem; 1987 Oct; 168(2):255-62. PubMed ID: 3665923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary surfactant films affected by solvent vapors.
    Enhorning G; Pototschnik R; Possmayer F; Burgoyne R
    Anesth Analg; 1986 Dec; 65(12):1275-80. PubMed ID: 3777456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antitubercular drugs on dipalmitoylphosphatidylcholine monolayers: implications for drug loaded surfactants.
    Chimote G; Banerjee R
    Respir Physiol Neurobiol; 2005 Jan; 145(1):65-77. PubMed ID: 15652789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraalveolar bubbles and bubble films: II. Formation in vivo through adulthood.
    Scarpelli EM; Mautone AJ; DeFouw DO; Clutario BC
    Anat Rec; 1996 Oct; 246(2):245-70. PubMed ID: 8888967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.
    Revak SD; Merritt TA; Degryse E; Stefani L; Courtney M; Hallman M; Cochrane CG
    J Clin Invest; 1988 Mar; 81(3):826-33. PubMed ID: 3343343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.